Myriad Genetics (NASDAQ:MYGN) Announces Quarterly Earnings Results, Beats Expectations By $0.09 EPS
The Cerbat Gem - 2024-05-07T19:04:55.000Z

Myriad Genetics (NASDAQ:MYGN – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.09, Briefing.com reports. The business had revenue of $202.20 million during the quarter, compared to analyst estimates of $193.51 million. Myriad Genetics had a negative net […]

In related news

Akamai Technologies (NASDAQ:AKAM) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS
Akamai Technologies (NASDAQ:AKAM – Get Free Report) announced its earnings results on Thursday. The technology infrastructure company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.61 by $0.03, Briefing.com reports. The business had revenue of $986.97 million for the quarter, compared to analyst estimates of $989.03 million. Akamai Technologies […]
- Related Articles
- In News
- From The Cerbat Gem
- 2024-05-09T19:58:41.000Z
Synaptics (NASDAQ:SYNA) Posts Earnings Results, Beats Expectations By $0.04 EPS
Synaptics (NASDAQ:SYNA – Get Free Report) released its quarterly earnings results on Thursday. The software maker reported $0.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.49 by $0.04, Briefing.com reports. Synaptics had a positive return on equity of 3.01% and a negative net margin of 7.54%. The business had revenue […]
- Related Articles
- In News
- From The Cerbat Gem
- 2024-05-09T18:54:43.000Z
Kyverna Therapeutics (NASDAQ:KYTX) Posts Quarterly Earnings Results, Misses Expectations By $0.28 EPS
Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) announced its earnings results on Tuesday. The company reported ($1.12) earnings per share for the quarter, missing the consensus estimate of ($0.84) by ($0.28), Briefing.com reports. During the same period in the previous year, the firm posted ($12.10) earnings per share. Kyverna Therapeutics Trading Up 2.4 % Kyverna […]
- Related Articles
- In News
- From The Cerbat Gem
- 2024-05-15T19:18:41.000Z

In related news

Akamai Technologies (NASDAQ:AKAM) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Synaptics (NASDAQ:SYNA) Posts Earnings Results, Beats Expectations By $0.04 EPS

Kyverna Therapeutics (NASDAQ:KYTX) Posts Quarterly Earnings Results, Misses Expectations By $0.28 EPS